�������

The researchers think therapies targeted at KRAS mutations can flag target proteins for immunotherapy attack.

Finding key biomarkers could lead to earlier, faster diagnosis.

New biotechnology uses targeted drugs to mark them for another kind of attack.

Dr. Dafna Bar-Sagi’s research examines how different levels of the environment affect tumor behavior.

Blocking calcium signals’ action in immune cells counters asthma without reducing flu defenses, study shows.

The norovirus infection blocks the release of protein meant to protect gut lining cells from damage.

Dr. Janice Mehnert says giving pembrolizumab before and after surgery is a potentially new standard of care.

The findings may help explain how the coronavirus continues to develop resistance to treatment.

People with pancreatic cancer who exercise show a doubled survival rate over a five-year period.

Researchers discover a way to jam the “ejection button” used by common bacteria to repel antibiotics.